Home/Supreme Court/GlaxoSmithKline v. Classen Immunotherapies, Inc.

GlaxoSmithKline v. Classen Immunotherapies, Inc.

568 U.S. 1137, 133 S. Ct. 973, 184 L. Ed. 2d 751, 81 U.S.L.W. 3389, 2013 WL 141405, 2013 U.S. LEXIS 648
Supreme Court of the United States·Decided January 14, 2013·No. No. 11-1078·Published

Opinion

C. A. Fed. Cir. Certiorari denied.

Justice Alito took no part in the consideration or decision of this petition.

Free access — add to your briefcase to read the full text and ask questions with AI

GlaxoSmithKline v. Classen Immunotherapies, Inc., 568 U.S. 1137, 133 S. Ct. 973, 184 L. Ed. 2d 751, 81 U.S.L.W. 3389, 2013 WL 141405, 2013 U.S. LEXIS 648 (2013).

568 U.S. 1137 (GlaxoSmithKline v. Classen Immunotherapies, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.